Dextrose

Dextrose

SCHEMBL1706844

O=C(O)c1ccc(O)c(O)c1.OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O.OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O.OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O.OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.54
CA1 P00915 4/20 0.54
CA2 P00918 4/20 0.54
CA9 Q16790 4/20 0.54
KDM4E B2RXH2 2/20 0.54
MAPT P10636 2/20 0.54
GAA P10253 2/20 0.54
CA12 O43570 1/20 0.54
POLB P06746 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
PTGS2 P35354 1/20 0.54
CA7 P43166 1/20 0.54
CA14 Q9ULX7 1/20 0.54
AKR1B1 P15121 1/20 0.51
HK1 P19367 3/20 0.51
HK2 P52789 3/20 0.51
ECE1 P42892 1/20 0.47
MUS81 Q96NY9 1/20 0.47
PYGL P06737 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Terephthalic Acid SCHEMBL9397547 0.86 PYGL (0.53) CA1CA2CA9HK1HK2
Gallic Acid SCHEMBL27897379 0.85 AKR1B1 (0.60) L3MBTL1CA1CA2CA9KDM4E
Dextrose SCHEMBL1706777 0.82 CA12 (0.63) CA1CA2CA9GAACA12
Dextrose SCHEMBL19252827 0.80 HK1 (0.53) KDM4EPOLBHK1HK2PYGL
SCHEMBL1706253 0.79 SLC28A3 (0.56) L3MBTL1KDM4EMAPTGAAECE1
SCHEMBL17653968 0.79 PPARG (0.59) L3MBTL1KDM4EMAPTGAAECE1
Protocatechuic Acid SCHEMBL27897569 0.76 CA12 (0.95) L3MBTL1CA1CA2CA9KDM4E
Ribose (Furanose) SCHEMBL19717961 0.75 NAPRT (0.53) MAPTHK1HK2PYGLCYP3A4
Ribose (Furanose) SCHEMBL16703138 0.74 SLC28A3 (0.47) HK1HK2
Dextrose SCHEMBL31515450 0.74 LGALS1 (0.50) CA1CA2CA9KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828407-B2 Water soluble and activable phenolic derivatives with dermocosmetic and therapeutic applications and process for preparing said derivatives LIBRAGEN (FR) 2017-11-28 US disclosed
US-20140088030-A1 WATER SOLUBLE AND ACTIVABLE PHENOLICS DERIVATIVES WITH DERMOCOSMETIC AND THERAPEUTIC APPLICATIONS AND PROCESS FOR PREPARING SAID DERIVATIVES LIBRAGEN (FR) 2014-03-27 US disclosed
EP-2027279-B1 Phenolic compounds with cosmetic and therapeutic applications LIBRAGEN (FR) 2012-04-18 EP disclosed
US-20090233876-A1 Water Soluble and Activable Phenolics Derivatives with Dermocosmetic and Therapeutic Applications and Process for Preparing Said Derivatives LIBRAGEN (FR) 2009-09-17 US disclosed
EP-1867729-A1 Water soluble phenolics derivatives with dermocosmetic and therapeutic applications Libragen (FR) 2007-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233876-A1 Water Soluble and Activable Phenolics Derivatives with Dermocosmetic and Therapeutic Applications and Process for Preparing Said Derivatives UGGT1, TYR, LCT L3MBTL1 2542/4885CA1 4389/4885CA2 2516/4885
US-20140088030-A1 WATER SOLUBLE AND ACTIVABLE PHENOLICS DERIVATIVES WITH DERMOCOSMETIC AND THERAPEUTIC APPLICATIONS AND PROCESS FOR PREPARING SAID DERIVATIVES UGGT1, TYR, G6PD L3MBTL1 2718/4885CA1 4503/4885CA2 2791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.